Mark Panozzo

Regional Sales Manager at CDx Diagnostics - Suffern, NY, US

Mark Panozzo's Colleagues at CDx Diagnostics
Danielle Shelton

Clinical Data Research Coordinator

Contact Danielle Shelton

Blake Goin

Associate Sales Representative

Contact Blake Goin

Stephen Frist

Consultant Research Pathologist - Computer Assisted Surgical Pathology and Cytology

Contact Stephen Frist

Ilana Roth

Research and Data Analyst

Contact Ilana Roth

Jacob Schreiber

Pathologist, Lab Director

Contact Jacob Schreiber

View All Mark Panozzo's Colleagues
Mark Panozzo's Contact Details
HQ
212-867-1762
Location
United States
Company
CDx Diagnostics
Mark Panozzo's Company Details
CDx Diagnostics logo, CDx Diagnostics contact details

CDx Diagnostics

Suffern, NY, US • 100 - 249 Employees
Medical Equipment

The mission of CDx Diagnostics® is to provide clinicians with easily implemented, cost-effective tools to preempt cancer through enhanced detection of precancerous cellular changes. This is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods. CDx tests require only a few minutes of practice time, are highly cost-effective, widely reimbursed, and address a recognized critical gap in the current diagnostic standard of care that results in thousands of otherwise unnecessary cancer deaths each year. Routine clinical use of CDx testing has already detected thousands of precancerous cells that would otherwise have been missed in time for effective endoscopic treatment and application of the CDx diagnostic platform to prevent cancers of the bile duct, stomach, and IBD affected colon is currently in progress.About WATS3DWATS3D addresses the major inadequacies inherent in current random forceps biopsy testing of the esophagus. In just a few minutes, endoscopists can easily obtain a wide area, full-thickness transepithelial specimen for computer-assisted 3D laboratory analysis prior to diagnosis by any WATS3D certified pathologist. In large multicenter clinical trials, WATS3D has been found to significantly increase the detection rate of both Barrett's esophagus and esophageal dysplasia. The high sensitivity and inter-observer agreement of WATS3D is due to the larger tissue area sampled, and the proprietary 3-Dimensional computer imaging system that is based on an artificial intelligence algorithm developed as part of the U.S. Strategic Defense Initiative missile defense program. To learn more about WATS3D, visit www.wats3d.com.

Detection of Oral Dysplasia & Cancer Detection of Esophoageal Dysplasia & Cancer Early Detection of Barrett's Esophagus Detection of Laryngeal Dysplasia & Cancer Prevention of Oral Cancer Prevention of Esophageal Cancer Detection of Oral Dysplasia & Cancer Detection of Esophoageal Dysplasia & Cancer Early Detection of Barrett's Esophagus Detection of Laryngeal Dysplasia & Cancer Screening for Barrett's Esophagus Surveillance of Barrett's Esophagus EGD esophagogastroduodenoscopy Prevention of Oral Dysplasia GERD Heartburn Endoscopy Gastroenterology GI Surgery Medical Equipment Medical and Hospital Equipment Medical Devices Health Care Services Hospitals Health Care
Details about CDx Diagnostics
Frequently Asked Questions about Mark Panozzo
Mark Panozzo currently works for CDx Diagnostics®.
Mark Panozzo's role at CDx Diagnostics® is Regional Sales Manager.
Mark Panozzo's email address is ***@cdxdiagnostics.com. To view Mark Panozzo's full email address, please signup to ConnectPlex.
Mark Panozzo works in the Medical Practice industry.
Mark Panozzo's colleagues at CDx Diagnostics are Danielle Shelton, Harrison Leblanc, Blake Goin, Stephen Frist, Ilana Roth, Jacob Schreiber, Ellen Rutenberg and others.
Mark Panozzo's phone number is 212-867-1762
See more information about Mark Panozzo